Complications and morbidity (6 ‐ 8 weeks) · malnourished or nutritionally at‐risk adults
1 finding from 1 review
Health‐related quality of life and patient satisfaction · malnourished or nutritionally at‐risk adults
1 finding from 1 review
Hospitalisation and institutionalisation (days) · malnourished or nutritionally at‐risk adults
1 finding from 1 review
Adverse events · malnourished or nutritionally at‐risk adults
1 finding from 1 review
Change in weight (kg) · malnourished or nutritionally at‐risk adults
1 finding from 1 review
Costs · malnourished or nutritionally at‐risk adults
1 finding from 1 review
Percentage of participants reaching PASI 75 · psoriasis
Dietary intervention may leads to higher severity of psoriasis PASI 75 (the proportion of participants… compared with usual care (low certainty).
1 finding from 1 review
Change in DLQI score (LOCF) · psoriasis
1 finding from 1 review
Time to relapse Not measured · psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in BMI · psoriasis
1 finding from 1 review
Improvement in vertigo · adults with vestibular migraine
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in vertigo (global score) · adults with vestibular migraine
1 finding from 1 review
Change in vertigo frequency · adults with vestibular migraine
1 finding from 1 review
Serious adverse events · adults with vestibular migraine
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
BMI short‐term (12 weeks from baseline to < 9 months) · children aged 5 to 11 years
1 finding from 1 review
Body‐mass index (BMI) · children aged 5 to 11 years
2 findings from 1 review
zBMI short term (12 weeks from baseline to < 9 months) · children aged 5 to 11 years
1 finding from 1 review
zBMI medium term (9 months to < 15 months) · children aged 5 to 11 years
1 finding from 1 review
zBMI long term (> 15 months) · children aged 5 to 11 years
1 finding from 1 review
Serious adverse events · children aged 5 to 11 years
1 finding from 1 review